IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma

NCT06688175 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Neoplasms
Elderly
Chemotherapy

Interventions

DRUG: IMRT combined with lobaplatin-based concurrent chemotherapy

Sponsor

The First Affiliated Hospital of Xiamen University